<DOC>
	<DOCNO>NCT02299089</DOCNO>
	<brief_summary>This Phase II , open-label multicentre , randomise study ass PK , PD , efficacy , safety two dose regimen CAM2029 adult patient acromegaly functional , well-differentiated NET , carcinoid symptom .</brief_summary>
	<brief_title>Phase II Study Subcutaneous Injection Depot Octreotide Patients With Acromegaly Neuroendocrine Tumours ( NETs )</brief_title>
	<detailed_description>This Phase II , open-label multicentre , randomise study ass PK , PD , efficacy , safety two dose regimen CAM2029 adult patient acromegaly functional , well-differentiated NET , carcinoid symptom , treat least 2 month Sandostatin LAR dose 10 mg , 20 mg , 30 mg start Sandostatin LAR Last Dose Assessment Phase ( Day -28 ) .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Acromegaly : Male female patient ≥18 year age Acromegaly currently treat Sandostatin LAR NET : Male female patient ≥18 year age Functional , welldifferentiated ( Grade 1 Grade 2 ) NET symptom carcinoid syndrome ( number bowel movement and/or flush ) Currently treat Sandostatin LAR symptom control Acromegaly : Inadequate bone marrow function Abnormal coagulation chronic treatment warfarin coumarin derivates Impaired liver , cardiac and/or renal function Known gallbladder , bile duct disease pancreatitis Diabetes poorly control blood glucose level despite adequate therapy Hypothyroidisms adequately treat NET : Poorly differentiate neuroendocrine carcinoma , highgrade neuroendocrine carcinoma , adenocarcinoid , pancreatic islet cell carcinoma , insulinoma , glucagonoma , gastrinoma , goblet cell carcinoid , typical atypical lung carcinoid , large cell neuroendocrine carcinoma small cell carcinoma Carcinoid syndrome refractory treatment conventional dos somatostatin analogue ( SSAs ) Inadequate bone marrow function Abnormal coagulation chronic treatment warfarin coumarin derivates Impaired liver , cardiac and/or renal function Known gallbladder , bile duct disease pancreatitis Shortbowel syndrome Diabetics poorly control blood glucose level despite adequate therapy Hypothyroidism , adequately treat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>acromegaly</keyword>
	<keyword>neuroendocrine tumour ( NET )</keyword>
	<keyword>carcinoid syndrome</keyword>
	<keyword>octreotide</keyword>
	<keyword>Sandostatin LAR</keyword>
</DOC>